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Diseases have traditionally been defined predominantly
by clinical criteria, sometimes with the assistance of “con-
ventional” laboratory data. Recent advances in genomic
technology have begun to find previously undiscovered
sub-divisions within what were thought to be single
diagnoses, sometimes with significant clinical implica-
tions. This talk will discuss the potential for such tech-
nologies to redefine the classification and treatment of
autoimmune diseases, using two recent examples from
Cambridge.
The first is the use of a Genome Wide Association Study
to determine the genetic underpinning of ANCA-
associated Vasculitis (AAV). This study has confirmed
a genetic component to AAV pathogenesis, and demon-
strated that the AAV clinical syndromes granulomatosis
with polyangiitis (GPA: formerly Wegener’s) and micro-
scopic polyangiitis (MPA) are genetically distinct diseases
better defined by ANCA specificity for proteinase-3 (PR3)
or myeloperoxidase (MPO) rather than clinical syndrome.
In addition the response against the autoantigen PR3
(encoded by PRTN3) was found to be a central etiological
feature of PR3-ANCA associated vasculitis. Thus PR3-
and MPO-ANCA-associated vasculitis must be considered
as distinct autoimmune syndromes [1].
The second example will describe the use of whole
genome transcriptome analysis of purified CD8 T cells to
define two sub-groups within patients with a number of
inflammatory diseases (including SLE, AAV, Crohn’s
disease and ulcerative colitis). These otherwise “invisible”
groups have markedly different long term outcomes [2,3].
This has implications for therapy, and has led to the
development of a biomarker now entering clinical trials.
Follow-up studies have led to the discovery of a new
inflammatory pathway controlling TNFa and IL-10
production that might drive this difference in outcome.
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